HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Treatment of chronic glomerulonephritis with cytostatics].

Abstract
A retrospective analysis was made of the efficacy of oral treatment with cytostatics (azathioprin, batriden, cyclophosphamide) in 109 patients with chronic glomerulonephritis (CGN) (with a known morphologic appearance in 94 patients) and with excessive doses of cyclophosphamide i. v. in 32 patients with CGN depending on the nephritis standing, its clinical pattern and morphologic variant. The best results were recorded with nephritis lasting up to 2 years in patients suffering from the nephrotic pattern of CGN or at the stage of the nephrotic syndrome formation in patients with latent CGN, in membranoproliferative, membranous and membranocapillary versions of CGN, during pulse therapy, and in patients with focal segmental glomerulohyalinosis. No remissions were observed in mixed CGN. The experimental data are also provided concerning the influence of a single oral cyclophosphamide administration on the morphologic signs of nephritis in GBA and C57BL mice.
AuthorsI E Tareeva, N B Gordovskaia, O P Gladskikh, A A Ivanov, T N Krasnova
JournalTerapevticheskii arkhiv (Ter Arkh) Vol. 61 Issue 6 Pg. 9-14 ( 1989) ISSN: 0040-3660 [Print] Russia (Federation)
Vernacular TitleLechenie khronicheskogo glomerulonefrita tsitostatikami.
PMID2799726 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Immunosuppressive Agents
  • batridene
  • Cyclophosphamide
  • Gossypol
  • Azathioprine
Topics
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • Azathioprine (therapeutic use)
  • Chronic Disease
  • Cyclophosphamide (therapeutic use)
  • Glomerulonephritis (drug therapy)
  • Gossypol (analogs & derivatives)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred CBA
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: